6 results match your criteria: "Dell Medical School at Austin[Affiliation]"
Cutis
January 2023
Dr. Bambekova is from the University of Texas Health San Antonio, Long School of Medicine. Drs. Cervantes, Reichenberg, and Ruth are from the Department of Dermatology, Dell Medical School at Austin/Dell Children's Hospital, Austin, Texas.
Cutis
March 2022
Dr. Patel is from the Long School of Medicine, University of Texas Health San Antonio. Drs. Cervantes, Keeling, and Adamson are from the Department of Internal Medicine, Division of Dermatology, Dell Medical School at Austin, Texas.
JAMA Dermatol
April 2021
Section of Dermatology, Division of Pediatric Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Importance: Hidradenitis suppurativa (HS) in pediatric patients has been understudied. Increased awareness and recognition of HS prevalence in children demand efforts to better understand this condition.
Objective: To describe the demographics, clinical features, treatment, associated comorbidities, and outcomes in a large cohort of pediatric patients with HS.
Dermatol Online J
October 2020
Division of Dermatology, Department of Internal Medicine, Dell Medical School at Austin, Austin, TX.
A 90-year-old man presented for evaluation of an incompletely excised squamous cell carcinoma above the right brow, with pathology demonstrating tumor extending to resection margins with perineural invasion. A cord of tumor was noted to extend past the orbital rim and towards the posterior orbit. Mohs excision versus coordinated resection and reconstruction with colleagues in the head and neck surgery and craniofacial plastic surgery departments were considered.
View Article and Find Full Text PDFJ Am Acad Dermatol
February 2020
Saint Louis University, Department of Dermatology, St. Louis, Missouri.
Am J Psychiatry
April 2019
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Dunlop, LoParo, Kinkead, Mletzko-Crowe, Mayberg, Craighead); Research Design Associates, Inc., Yorktown Heights, New York (Cole); Institute for Early Life Adversity Research, University of Texas Dell Medical School at Austin (Nemeroff); Departments of Neurology and Neurosurgery, Icahn School of Medicine at Mount Sinai, New York (Mayberg); Department of Psychology, Emory University, Atlanta (Craighead).
Objective: Adults with major depressive disorder frequently do not achieve remission with an initial treatment. Addition of psychotherapy for patients who do not achieve remission with antidepressant medication alone can target residual symptoms and protect against recurrence, but the utility of adding antidepressant medication after nonremission with cognitive-behavioral therapy (CBT) has received little study. The authors aimed to evaluate the acute and long-term outcomes resulting from both sequences of combination treatments.
View Article and Find Full Text PDF